Sunday, November 13, 2016

AASLD 2016 Liver Cancer Rare After HCV Therapy

Liver Cancer Rare After HCV Therapy
by Michael Smith Michael Smith
North American Correspondent, MedPage Today

But some patients develop aggressive form of the disease

BOSTON -- For patients with advanced liver disease owing to hepatitis C (HCV), treatment with direct-acting antiviral agents did not increase the risk of hepatocellular carcinoma, a researcher said here.

The risk of liver cancer in the first year after such therapy was pretty much the same as it is in untreated patients, according to Alfredo Alberti, MD, of the University of Padua in Italy.

On the other hand, the rare patients who developed cancer after HCV treatment were more likely to have an aggressive form of the disease, Alberti told reporters at the American Association for the Study of Liver Diseases (AASLD) annual meeting.

The findings, from a large prospective cohort of patients in northern Italy, should help to settle what has been a "controversial and confusing issue," Alberti said, with small studies yielding conflicting results on the issue.
Continue reading....

Additional Reading @ MedPage Today

Fibrosis Risk High in Kids With Transplanted Livers
Those with cirrhosis at risk of liver failure and graft loss
Marked Sex Difference Seen in Drug-Induced Liver Failure
Brain damage, polypharmacy more common in women with ALF
AASLD: HCV Outcomes Under Scrutiny
Treatment now 'predictably' good in trials but what about real world?
AASLD: Focus on Liver Broadens
Fatty liver disease expected to get lion's share of spotlight

Current updates: Conference Reports
Updates On This Blog: AASLD 2016

No comments:

Post a Comment